Home/Filings/4/0001181431-12-058538
4//SEC Filing

Peroutka Stephen J 4

Accession 0001181431-12-058538

CIK 0001385830other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 3:45 PM ET

Size

7.0 KB

Accession

0001181431-12-058538

Insider Transaction Report

Form 4
Period: 2012-11-09
Peroutka Stephen J
Executive V.P. and CMO
Transactions
  • Exercise/Conversion

    Common Stock

    2012-11-09+18,75018,750 total
  • Exercise/Conversion

    Restricted Stock Units

    2012-11-0918,75056,250 total
    Exercise: $0.00Common Stock (18,750 underlying)
Footnotes (3)
  • [F1]The restricted stock units shall vest as follows: twenty-five percent (25%) of the total number of shares subject to such grant shall vest on November 9, 2012 and twenty-five percent (25%) of the total number of shares subject to such grant shall vest annually thereafter, subject to the grantee's continued service relationship with the Company.
  • [F2]Restricted Stock Units do not expire.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of NeurogesX, Inc. common stock.

Issuer

NeurogesX Inc

CIK 0001385830

Entity typeother

Related Parties

1
  • filerCIK 0001534573

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 3:45 PM ET
Size
7.0 KB